Lennart Mulder

In January 2016, I joined the group of Jelle Wesseling. Primarily, my work focuses on molecular profiling of DCIS specimens to identify and validate features distinguishing aggressive from harmless DCIS. Secondarily, I work on multi-omics profiling of breast cancer specimens to discover biomarkers for neoadjuvant chemotherapy sensitivity.